U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H17N5O4
Molecular Weight 379.3694
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Ervogastat metabolite M3

SMILES

OC1=CC=CN=C1OC2=CN=CC(=C2)C3=NC=C(C=N3)C(=O)N[C@H]4CCOC4

InChI

InChIKey=NGHYSANESYWITP-AWEZNQCLSA-N
InChI=1S/C19H17N5O4/c25-16-2-1-4-21-19(16)28-15-6-12(7-20-10-15)17-22-8-13(9-23-17)18(26)24-14-3-5-27-11-14/h1-2,4,6-10,14,25H,3,5,11H2,(H,24,26)/t14-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H17N5O4
Molecular Weight 379.3694
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:13:53 UTC 2023
Edited
by admin
on Sat Dec 16 19:13:53 UTC 2023
Record UNII
GB2PA62UHB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Ervogastat metabolite M3
Common Name English
(S)-2-(5-((3-Hydroxypyridin-2-yl)oxy)pyridin-3-yl)-N-(tetrahydrofuran-3-yl)pyrimidine-5-carboxamide
Systematic Name English
Code System Code Type Description
FDA UNII
GB2PA62UHB
Created by admin on Sat Dec 16 19:13:53 UTC 2023 , Edited by admin on Sat Dec 16 19:13:53 UTC 2023
PRIMARY
PUBCHEM
166451403
Created by admin on Sat Dec 16 19:13:53 UTC 2023 , Edited by admin on Sat Dec 16 19:13:53 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE